Ni Zeng

1.5k citations
36 papers · 1.1k indexed · 1 hit paper · h-index 18
Topics
Advanced Drug Delivery Systems (6 papers)Ocular Surface and Contact Lens (4 papers)Advancements in Transdermal Drug Delivery (3 papers)
Partner nations
ChinaFranceUnited States

In The Last Decade

Ni Zeng

35 papers receiving 1.1k citations

Hit Papers

Post-traumatic osteoarthritis following ACL injury2020202620222024202050100150

Peers

Ni Zeng
Comparison fields: 5 of 105
  • Molecular Biology 392
  • Pharmaceutical Science 255
  • Biomaterials 134
  • Surgery 130
  • Public Health, Environmental and Occupational Health 130
Replace Chuanlong Guo with:
Chuanlong Guo China
Kazunori Iwanaga Japan
Chandraiah Godugu India
Rajitha Panonnummal India
Jiaxin Li China
Amany O. Kamel Egypt
Maryam Kouchak Iran
Bin Lü China
Felisa Cilurzo Italy
Ni Zeng relative to Chuanlong Guo China Chuanlong Guo's profile →
Citations per field
00.5×1.5×1.9×
Chuanlong Guo · 1×
Citations per year

Countries citing papers authored by Ni Zeng

Since Specialization
Citations

This map shows the geographic impact of Ni Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ni Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ni Zeng more than expected).

Fields of papers citing papers by Ni Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ni Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ni Zeng. The network helps show where Ni Zeng may publish in the future.

Co-authorship network of co-authors of Ni Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Ni Zeng. A scholar is included among the top collaborators of Ni Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ni Zeng. Ni Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 2
4 0
5 2
6 8
7 3
8 9
9
Post-traumatic osteoarthritis following ACL injurybreakdown →
162
10 29
11 15
12 2
13 33
14 60
15 3
16 36
17 33
18 55
19 65
20 122

About Ni Zeng

Ni Zeng is a scholar working on Pharmaceutical Science, Nephrology and Molecular Medicine, having authored 36 papers that have together received 1.1k indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (6 papers), Ocular Surface and Contact Lens (4 papers) and Advancements in Transdermal Drug Delivery (3 papers). The work is most often cited by research in Pharmaceutical Science (255 citations), Molecular Medicine (74 citations) and Biomaterials (134 citations). Ni Zeng has collaborated with scholars based in China, France and United States. Frequent co-authors include Guoxin Ni, Jie‐Ting Li, Zhi-Peng Yan, Nathalie Mignet, Vincent Boudy, Guowen Zhang, Lijuan Wang, Junhui Pan, Deming Gong and Xing Hu. Their work appears in journals such as Gastroenterology, Biomaterials and Analytical Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026